Jump to ContentJump to Main Navigation
Human Tissue ResearchA European perspective on the ethical and legal challenges$
Users without a subscription are not able to see the full content.

Christian Lenk, Nils Hoppe, Katharina Beier, and Claudia Wiesemann

Print publication date: 2011

Print ISBN-13: 9780199587551

Published to Oxford Scholarship Online: May 2011

DOI: 10.1093/acprof:oso/9780199587551.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 06 December 2021

Informed consent when donating cells for the production of human tissue engineered products

Informed consent when donating cells for the production of human tissue engineered products

(p.149) Chapter 15 Informed consent when donating cells for the production of human tissue engineered products
Human Tissue Research

Leen Trommelmans

Joseph Selling

Kris Dierickx

Oxford University Press

Donated cells are essential for the creation of human tissue engineered products. Informed consent by the donor is required under EU regulation. Because cell donation will be more likely if the cells's use is consistent with the donors' world views, the various values that donors attach to cells must be taken into account when designing the informed consent procedure. This chapter identifies four, sometimes contradictory, connotations of value: biological, financial, relational, and informational value. Respecting these different values may lead to different ethical precepts regarding cell donation. The chapter investigates how these values may influence cell donation for various tissue engineering purposes. It also indicates that consenting to cell donation assumes some characteristics of a contract. Giving preference to one type of cell value over other types of value may furthermore influence which relationships between the various stakeholders in tissue engineering are privileged, and consequently how the future development and regulatory framework of tissue engineering and regenerative medicine may have to evolve, and what the contents of the informed consent should be.

Keywords:   informed consent, cell donation, tissue engineering, regenerative medicine, value of cells

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .